- Corporate Tax Reform including House BluePrint and Border Adjustablity. S 1390, "Strong Patents Act", provisions relating to patent reform. H.R. 2051, "FAST Generics Act of 2017", provisions regarding REMS.

H.R. 1409, "Cancer Drug Parity Act of 2017", regarding all provisions.

H.R. 2077, "Restoring the Patient's Voice Act of 2017", Step Therapy / Fail First.

S.974, "CREATES Act of 2017", provisions regarding REMS.

H.R. 849, "Protecting Seniors' Access to Medicare Act of 2017", regarding IPAB.

Issues relating to Medicare Part D / Part B and the Affordable Care Act.

Regulation of Non-Biological Complex Drugs.
TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CELGENE CORPORATION
86 Morris Ave, Summit, NJ, 07901, US
PATRICK GLIHA ERIN POLAK PATRICK GLIHA MATTHEW SCHUMAKER PATRICK GLIHA ERIN POLAK